Companies » Company Overview » Ranbaxy Laboratories Ltd.
 
 
  • BSE: 500359
  • NSE: RANBAXY
  • ISIN Code: INE015A01028
  • Sector: Health care
bse
13:52 PM,4th Mar 2015
793.10
61.95 (8.47%)
Open 728.00
Day High 803.10
Day Low 725.00
Previous Close 731.15
Volume 323792
52-Week high 803.10
52-Week low 335.00
P/E -
Mkt Cap.(Rs cr) 33759
NSE
13:45 PM,4th Mar 2015

795.85
62.85 (8.57%)
Bse
13:52 PM,4th Mar 2015

793.10
61.95 (8.47%)
nse
13:45 PM,4th Mar 2015
795.85
62.85 (8.57%)
Open 732.25
Day High 803.80
Day Low 725.00
Previous Close 733.00
Volume 2304144
52-Week high 803.80
52-Week low 335.00
P/E -
Mkt Cap.(Rs cr) 33759

Ranbaxy Laboratories Ltd. (RANBAXY) - Company Information

Ranbaxy Laboratories Ltd, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy today has a presence in 23 of the top 25 pharmaceutical markets of the world. The company has a global footprint in 46 countries, world-class manufacturing facilities in 8 countries and serves customers in over 125 count... [More]

Key Fundamentals
Market Cap (Rs cr) 33,759
EPS - TTM (Rs)

[*C]

-
P/E Ratio (x)

[*C]

-
Face Value (Rs) 5
Latest Dividend (%) 40.00
Latest Dividend Date 28 Apr 2011
Dividend Yield (%) 0.00
Book Value / Share (Rs)

[*C]

77.51
P/B Ratio (x)

[*C]

10.23
[*C] Consolidated [*S] Standalone
STOCK STRENGTH
Today's Low/High
725.00
803.10
Week Low/High
667.60
803.10
Month Low/High
667.60
803.10
YEAR Low/High
335.00
803.10
All TIME Low/High
4.75
803.10
Peer Group
Company Last Change(%)
Aurobindo Pharma 1097.05 -0.05
Cadila Health. 1534.95 0.26
Glenmark Pharma. 807.90 1.08
Torrent Pharma. 1121.95 3.52
Wockhardt 1670.55 0.46
Piramal Enterp. 898.00 -0.06
Dr Reddy's Labs 3445.00 1.02
Returns
Period Ranbaxy Labs. Sensex NIFTY
1 Week 15.30% 2.74% 3.27%
1 Month 7.52% 3.18% 3.78%
3 Month 26.38% 4.34% 5.71%
6 Month 20.91% 10.03% 11.83%
1 Year 119.06% 40.52% 43.76%
3 Year 86.24% 68.98% 68.93%
Period Ranbaxy Labs. Sensex NIFTY
1 Week 15.53% 2.74% 3.27%
1 Month 7.99% 3.18% 3.78%
3 Month 26.85% 4.34% 5.71%
6 Month 21.25% 10.03% 11.83%
1 Year 119.82% 40.52% 43.76%
3 Year 86.95% 68.98% 68.93%
Financial Results
Particulars (Rs cr) Dec 2014 Dec 2013 %Chg
Net Sales 2618.85 2893.99 -9.51
Other Income 10.68 138.8 -92.31
Total Income 2629.53 3032.8 -13.3
Total Expenses 2521.24 2881.08 -12.49
Operating Profit 108.29 151.72 -28.63
Net Profit -1023.61 -158.49 -545.85
Equity Capital 212.24 211.55 -
SHAREHOLDING PATTERN
As on Dec 2014
Research Reports
Date Broker Action Price Report
28/01 Motilal Oswal Buy 700 PDF Icon
28/01 IDFC Outperform 700 PDF Icon
03/11 Angel Broking Neutral 634 PDF Icon
28/10 Motilal Oswal Buy 634 PDF Icon
28/10 Prabhudas Lilladhar Accumulate 634 PDF Icon
Board of directors
Director : Takashi Shoda
Chairman : Tsutomu Une
Director : Rajesh V Shah
Company Secretary : S K Patawari
Managing Director & CEO : Arun Sawhney
Director : Anthony H Wild
Director : Akihiro Watanabe
Director : Kazunori Hirokawa
Director : Percy K Shroff
AUDITOR: BSR & Co LLP
IND NAME: Pharmaceuticals - Indian - Bulk Drugs & Formln
HOUSE NAME: MNC Associate
Registered office
Plot No 90, Sector 32,
Gurgaon,Haryana-122001
Ph: 91-0124-4135000
E-mail:
URL: http://www.ranbaxy.com

Quick Links

Quick Links for Ranbaxy Laboratories

Back to Top